VTX-2337, a TLR8 agonist, plus chemotherapy in recurrent ovarian cancer: Preclinical and phase 1 data by the gynecologic oncology group Meeting Abstract
| Authors: | Monk, B. J.; Brady, W. E.; Lankes, H. A.; Facciabene, A.; Manjarrez, K. L.; Hershberg, R. M.; Fracasso, P. M.; Bell-Mcguinn, K. M.; Walker, J. L.; McCourt, C. K.; Aghajanian, C.; Coukos, G. |
| Abstract Title: | VTX-2337, a TLR8 agonist, plus chemotherapy in recurrent ovarian cancer: Preclinical and phase 1 data by the gynecologic oncology group |
| Meeting Title: | 10th Biennial Ovarian Cancer Research Symposium |
| Journal Title: | Clinical Cancer Research |
| Volume: | 21 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2014 Sep 8-9 |
| Meeting Location: | Seattle, WA |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-08-15 |
| Language: | English |
| ACCESSION: | WOS:000361386100023 |
| DOI: | 10.1158/1557-3265.ovcasymp14-as27 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: AS27 -- Source: Wos |
